SUBSTITUTED PYRAZOLO-QUINAZOLINE DERIVATIVES AS KINASE INHIBITORS

FIELD: biochemistry.SUBSTANCE: present invention relates to novel pyrazolo [4,3-h]quinazoline compounds selected from the group indicated below and corresponding to general formula (I). Cell proliferative disorders is selected from the group consisting of benign prostate hyperplasia, familial adenom...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PYUTTI Klaudia, ERMOLI Antonella, KAZUSHELLI Franchesko, FAYARDI Daniela
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:FIELD: biochemistry.SUBSTANCE: present invention relates to novel pyrazolo [4,3-h]quinazoline compounds selected from the group indicated below and corresponding to general formula (I). Cell proliferative disorders is selected from the group consisting of benign prostate hyperplasia, familial adenomatosis polyposis, neurofibromatosis, psoriasis, vascular smooth cell proliferation associated with atherosclerosis, pulmonary fibrosis, arthritis, glomerulonephritis and post-surgical stenosis and restenosis. Inflammatory and autoimmune diseases are selected from multiple sclerosis, systemic lupus erythematosis, inflammatory bowel diseases (IBD), Crohn's disease, irritable bowel syndrome, pancreatitis, ulcerative colitis, diverticulosis, myasthenia gravis, vasculitis, psoriasis, scleroderma, asthma, allergy, systemic sclerosis, vitiligo, arthritis such as osteoarthritis, juvenile rheumatoid arthritis, ankylosing spondylitis. Formula (I)where radicals A, R1-R3, R5 correspond to the values, said compounds, which are selected from 1-(2-hydroxyethyl)-8-(methylsulfanyl)-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide, 1-(2-hydroxyethyl)-8-methoxy-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide, 1-tert-butyl-N-methyl-8-(methylsulfanyl)-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide, 1-tert-butyl-N-[2-(dimethylamino)etliyl]-8-(metliylsulfanyl)-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide, 1-tert-butyl-N-(2-hydroxyethyl)-8-(methylsulfanyl)-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide, 1-tert-butyl-N-(1-methylpiperidin-4-yl)-8-(methylsulfanyl)-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide, 1-tert-butyl-N-[2-(1H-imidazol-5-yl)ethyl]-8-(methylsulfanyl)-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide, 1-[2-(dimethylamino)ethyl]-8-(methylsulfanyl)-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide, 6-amino-1-[2-(dimethylamino)ethyl]-8-(metliylsulfanyl)-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide, 2-[2-(dimethylamino)ethyl]-8-(methylsulfanyl)-2H-pyrazolo[4,3-h]quinazoline-3-carboxamide, 1-(2-aminoethyl)-8-(methylsulfanyl)-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide, 2-(2-aminoethyl)-8-(methylsulfanyl)-2H-pyrazolo[4,3-h]quinazoline-3-carboxamide, 8-(methylsulfanyl)-1-(piperidin-4-ylmethyl)-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide, 8-(methylsulfanyl)-2-(piperidin-4-ylmethyl)-2H-pyrazolo[4,3-h]quinazoline-3-carboxamide, 1-methyl-8-[4-(piperazin-1-yl)phenoxy]-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide, 1-methyl-8-phenoxy-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide, 8-(3-aminoph